Tumor regression by phenethyl isothiocyanate involves DDB2

References

• Sugasawa K, Okuda Y, Saijo M, Nishi R, Matsuda N, Chu G, et al. UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex. Cell 2005; 121:387 - 400; http://dx.doi.org/10.1016/j.cell.2005.02.035; PMID: 15882621
   PubMed Web of Science ®Google Scholar
• Stoyanova T, Roy N, Kopanja D, Bagchi S, Raychaudhuri P. DDB2 decides cell fate following DNA damage. Proc Natl Acad Sci USA 2009; 106:10690 - 5; http://dx.doi.org/10.1073/pnas.0812254106; PMID: 19541625
   PubMed Web of Science ®Google Scholar
• Nag A, Bondar T, Shiv S, Raychaudhuri P. The xeroderma pigmentosum group E gene product DDB2 is a specific target of cullin 4A in mammalian cells. Mol Cell Biol 2001; 21:6738 - 47; http://dx.doi.org/10.1128/MCB.21.20.6738-6747.2001; PMID: 11564859
   PubMed Web of Science ®Google Scholar
• Stoyanova T, Yoon T, Kopanja D, Mokyr MB, Raychaudhuri P. The xeroderma pigmentosum group E gene product DDB2 activates nucleotide excision repair by regulating the level of p21Waf1/Cip1. Mol Cell Biol 2008; 28:177 - 87; http://dx.doi.org/10.1128/MCB.00880-07; PMID: 17967871
   PubMed Web of Science ®Google Scholar
• Kapetanaki MG, Guerrero-Santoro J, Bisi DC, Hsieh CL, Rapić-Otrin V, Levine AS. The DDB1-CUL4ADDB2 ubiquitin ligase is deficient in xeroderma pigmentosum group E and targets histone H2A at UV-damaged DNA sites. Proc Natl Acad Sci USA 2006; 103:2588 - 93; http://dx.doi.org/10.1073/pnas.0511160103; PMID: 16473935
   PubMed Web of Science ®Google Scholar
• Luijsterburg MS, Lindh M, Acs K, Vrouwe MG, Pines A, van Attikum H, et al. DDB2 promotes chromatin decondensation at UV-induced DNA damage. J Cell Biol 2012; 197:267 - 81; http://dx.doi.org/10.1083/jcb.201106074; PMID: 22492724
   PubMed Web of Science ®Google Scholar
• Wang H, Zhai L, Xu J, Joo HY, Jackson S, Erdjument-Bromage H, et al. Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase facilitates cellular response to DNA damage. Mol Cell 2006; 22:383 - 94; http://dx.doi.org/10.1016/j.molcel.2006.03.035; PMID: 16678110
   PubMed Web of Science ®Google Scholar
• Stoyanova T, Roy N, Bhattacharjee S, Kopanja D, Valli T, Bagchi S, et al. p21 cooperates with DDB2 protein in suppression of ultraviolet ray-induced skin malignancies. J Biol Chem 2012; 287:3019 - 28; http://dx.doi.org/10.1074/jbc.M111.295816; PMID: 22167187
   PubMed Web of Science ®Google Scholar
• Stoyanova T, Roy N, Kopanja D, Raychaudhuri P, Bagchi S. DDB2 (damaged-DNA binding protein 2) in nucleotide excision repair and DNA damage response. Cell Cycle 2009; 8:4067 - 71; http://dx.doi.org/10.4161/cc.8.24.10109; PMID: 19923893
   PubMed Web of Science ®Google Scholar
• Roy N, Stoyanova T, Dominguez-Brauer C, Park HJ, Bagchi S, Raychaudhuri P. DDB2, an essential mediator of premature senescence. Mol Cell Biol 2010; 30:2681 - 92; http://dx.doi.org/10.1128/MCB.01480-09; PMID: 20351176
   PubMed Web of Science ®Google Scholar
• Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002; 1:639 - 49; PMID: 12479224
   PubMed Web of Science ®Google Scholar
• Campisi J, d’Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8:729 - 40; http://dx.doi.org/10.1038/nrm2233; PMID: 17667954
   PubMed Web of Science ®Google Scholar
• Minig V, Kattan Z, van Beeumen J, Brunner E, Becuwe P. Identification of DDB2 protein as a transcriptional regulator of constitutive SOD2 gene expression in human breast cancer cells. J Biol Chem 2009; 284:14165 - 76; http://dx.doi.org/10.1074/jbc.M808208200; PMID: 19339246
   PubMed Web of Science ®Google Scholar
• Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?. Nat Rev Drug Discov 2009; 8:579 - 91; http://dx.doi.org/10.1038/nrd2803; PMID: 19478820
   PubMed Web of Science ®Google Scholar
• Satyan KS, Swamy N, Dizon DS, Singh R, Granai CO, Brard L. Phenethyl isothiocyanate (PEITC) inhibits growth of ovarian cancer cells by inducing apoptosis: role of caspase and MAPK activation. Gynecol Oncol 2006; 103:261 - 70; http://dx.doi.org/10.1016/j.ygyno.2006.03.002; PMID: 16624391
   PubMed Web of Science ®Google Scholar
• Wang LG, Chiao JW. Prostate cancer chemopreventive activity of phenethyl isothiocyanate through epigenetic regulation (review). [review] Int J Oncol 2010; 37:533 - 9; http://dx.doi.org/10.3892/ijo_00000702; PMID: 20664922
   PubMed Web of Science ®Google Scholar
• Xiao D, Singh SV. Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases. Cancer Res 2002; 62:3615 - 9; PMID: 12097262
   PubMed Web of Science ®Google Scholar
• Xiao D, Zeng Y, Choi S, Lew KL, Nelson JB, Singh SV. Caspase-dependent apoptosis induction by phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent, is mediated by Bak and Bax. Clin Cancer Res 2005; 11:2670 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-04-1545; PMID: 15814648
   PubMed Web of Science ®Google Scholar
• Hu R, Kim BR, Chen C, Hebbar V, Kong AN. The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. Carcinogenesis 2003; 24:1361 - 7; http://dx.doi.org/10.1093/carcin/bgg092; PMID: 12819185
   PubMed Web of Science ®Google Scholar
• Khor TO, Cheung WK, Prawan A, Reddy BS, Kong AN. Chemoprevention of familial adenomatous polyposis in Apc(Min/+) mice by phenethyl isothiocyanate (PEITC). Mol Carcinog 2008; 47:321 - 5; http://dx.doi.org/10.1002/mc.20390; PMID: 17932952
   PubMed Web of Science ®Google Scholar
• Tan T, Chu G. p53 Binds and activates the xeroderma pigmentosum DDB2 gene in humans but not mice. Mol Cell Biol 2002; 22:3247 - 54; http://dx.doi.org/10.1128/MCB.22.10.3247-3254.2002; PMID: 11971958
   PubMed Web of Science ®Google Scholar
• Benhar M, Engelberg D, Levitzki A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep 2002; 3:420 - 5; http://dx.doi.org/10.1093/embo-reports/kvf094; PMID: 11991946
   PubMed Web of Science ®Google Scholar
• Park HJ, Carr JR, Wang Z, Nogueira V, Hay N, Tyner AL, et al. FoxM1, a critical regulator of oxidative stress during oncogenesis. EMBO J 2009; 28:2908 - 18; http://dx.doi.org/10.1038/emboj.2009.239; PMID: 19696738
   PubMed Web of Science ®Google Scholar
• Zhou XF, Shen XQ, Shemshedini L. Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization. Mol Endocrinol 1999; 13:276 - 85; http://dx.doi.org/10.1210/me.13.2.276; PMID: 9973257
   PubMed Web of Science ®Google Scholar
• Benkoussa M, Brand C, Delmotte MH, Formstecher P, Lefebvre P. Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter. Mol Cell Biol 2002; 22:4522 - 34; http://dx.doi.org/10.1128/MCB.22.13.4522-4534.2002; PMID: 12052862
   PubMed Web of Science ®Google Scholar
• Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 2006; 10:241 - 52; http://dx.doi.org/10.1016/j.ccr.2006.08.009; PMID: 16959615
   PubMed Web of Science ®Google Scholar
• Nogueira V, Park Y, Chen CC, Xu PZ, Chen ML, Tonic I, et al. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 2008; 14:458 - 70; http://dx.doi.org/10.1016/j.ccr.2008.11.003; PMID: 19061837
   PubMed Web of Science ®Google Scholar
• Bagchi S, Raychaudhuri P. Damaged-DNA Binding Protein-2 Drives Apoptosis Following DNA Damage. Cell Div 2010; 5:3; http://dx.doi.org/10.1186/1747-1028-5-3; PMID: 20205757
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307 - 10; http://dx.doi.org/10.1038/35042675; PMID: 11099028
   PubMed Web of Science ®Google Scholar
• Soussi T, Lozano G. p53 mutation heterogeneity in cancer. Biochem Biophys Res Commun 2005; 331:834 - 42; http://dx.doi.org/10.1016/j.bbrc.2005.03.190; PMID: 15865939
   PubMed Web of Science ®Google Scholar
• Vazquez A, Bond EE, Levine AJ, Bond GL. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov 2008; 7:979 - 87; http://dx.doi.org/10.1038/nrd2656; PMID: 19043449
   PubMed Web of Science ®Google Scholar
• Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 2002; 109:335 - 46; http://dx.doi.org/10.1016/S0092-8674(02)00734-1; PMID: 12015983
   PubMed Web of Science ®Google Scholar
• Vergel M, Marin JJ, Estevez P, Carnero A. Cellular senescence as a target in cancer control. J Aging Res 2010; 2011:725365; PMID: 21234095
   PubMedGoogle Scholar
• Itoh T, O’Shea C, Linn S. Impaired regulation of tumor suppressor p53 caused by mutations in the xeroderma pigmentosum DDB2 gene: mutual regulatory interactions between p48(DDB2) and p53. Mol Cell Biol 2003; 23:7540 - 53; http://dx.doi.org/10.1128/MCB.23.21.7540-7553.2003; PMID: 14560002
   PubMed Web of Science ®Google Scholar
• Zhao Q, Barakat BM, Qin S, Ray A, El-Mahdy MA, Wani G, et al. The p38 mitogen-activated protein kinase augments nucleotide excision repair by mediating DDB2 degradation and chromatin relaxation. J Biol Chem 2008; 283:32553 - 61; http://dx.doi.org/10.1074/jbc.M803963200; PMID: 18806262
   PubMed Web of Science ®Google Scholar
• Zhong SP, Ma WY, Dong Z. ERKs and p38 kinases mediate ultraviolet B-induced phosphorylation of histone H3 at serine 10. J Biol Chem 2000; 275:20980 - 4; http://dx.doi.org/10.1074/jbc.M909934199; PMID: 10806218
   PubMed Web of Science ®Google Scholar
• Cheung P, Allis CD, Sassone-Corsi P. Signaling to chromatin through histone modifications. Cell 2000; 103:263 - 71; http://dx.doi.org/10.1016/S0092-8674(00)00118-5; PMID: 11057899
   PubMed Web of Science ®Google Scholar
• Chaveroux C, Jousse C, Cherasse Y, Maurin AC, Parry L, Carraro V, et al. Identification of a novel amino acid response pathway triggering ATF2 phosphorylation in mammals. Mol Cell Biol 2009; 29:6515 - 26; http://dx.doi.org/10.1128/MCB.00489-09; PMID: 19822663
   PubMed Web of Science ®Google Scholar
• Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006; 1:2315 - 9; http://dx.doi.org/10.1038/nprot.2006.339; PMID: 17406473
   PubMed Web of Science ®Google Scholar